GOLIMUMAB AS FIRST, SECOND OR AT LEAST THIRD BIOLOGIC AGENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - POST HOC ANALYSIS OF A NON-INTERVENTIONAL STUDY IN GERMANY

被引：0

作者：

Krueger, Klaus

Burmester, Gerd Ruediger ^{[1
]}

Wassenberg, Siegfried ^{[2
]}

Thiele, Astrid ^{[3
]}

Thomas, Matthias ^{[4
]}

机构：

[1] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany

[2] Rheumazentrum Ratingen, Ratingen, Germany

[3] St Josefs Hosp, Wuppertal, Germany

[4] MSD Sharp & Dohme GmbH, Med Affairs, Haar, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.3245

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0166

引用

页码：1156 / 1157

页数：2

共 50 条

[1] Golimumab as First, Second or at Least Third Biologic Agent in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Post Hoc Analysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[2] Golimumab in Biologic-NaiVe Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis from a Non-Interventional Evaluation in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[3] Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
Klaus Krüger
Gerd Rüdiger Burmester
Siegfried Wassenberg
Matthias H. Thomas
Rheumatology and Therapy, 2020, 7 : 371 - 382
[4] Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
Krueger, Klaus
Burmester, Gerd Ruediger
Wassenberg, Siegfried
Thomas, Matthias H.
RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 371 - 382
[5] Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias H.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] A NON-INTERVENTIONAL CLINICAL STUDY EVALUATING THE USE OF GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA), AND ANKYLOSING SPONDYLITIS (AS) IN A REAL-LIFE SETTING IN GERMANY
Krueger, K.
Burmester, G. R.
Wassenberg, S.
Bohl-Buehler, M.
Thomas, M. H.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 232 - 232
[7] GOLIMUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - SUBANALYSIS FROM THE NON-INTERVENTIONAL EVALUATION GO-NICE
Krueger, K.
Burmester, G. R.
Wassenberg, S.
Bohl-Buehler, M.
Thomas, M. H.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 558 - 559
[8] Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): Interim Results from a Non-Interventional Trial in Germany
Krueger, Klaus
Remstedt, Sven
Thiele, Astrid
Klaudius, Ines
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[9] Non-Interventional Clinical Study Investigating the Use of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in Germany-3rd Interim Analysis
Thomas, Matthias H.
Krueger, Klaus
Aries, Pee
Bohl-Buehler, Martin
Brandt-Juergens, Jan
Rickert, Verena
Wassenberg, Siegfried
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[10] Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): 1-Year Results from a Non-Interventional Trial in Germany
Kruger, Klaus
Remstedt, Sven
Thiele, Astrid
Klaudius, Ines
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →